Showing results (81-90 of 536) with videos related to
Sort By:
Pageof 54
European Journal of Immunology|June 2, 2011
Early viral replication in lymph nodes provides HIV with a means by which to escape NK-cell-mediated controlRutger Luteijn, Gaia Sciaranghella, Jan van Lunzen, et al.Journal of Virology|January 28, 2021
Production of HIV-1 Env-specific antibodies mediating innate immune functions depends on cognate IL-21- secreting CD4+ T cellsJernej Pušnik, Stephanie Fischinger, Ulf Dittmer, et al.NPJ Vaccines|September 14, 2020
Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infectionDelphine C Malherbe, Arban Domi, Mary J Hauser, et al.Journal of Immunological Methods|October 2, 2012
High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samplesEric P Brown, Anna F Licht, Anne-Sophie Dugast, et al.American Journal of Obstetrics and Gynecology|April 17, 2022
Preserved recognition of Omicron spike following COVID-19 messenger RNA vaccination in pregnancyYannic C Bartsch, Caroline Atyeo, Jaewon Kang, et al.Cell Reports|June 19, 2021
Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell helpJernej Pušnik, Enrico Richter, Bianca Schulte, et al.Journal of Virology|June 26, 2009
Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infectionQingquan Liu, Yongtao Sun, Suzannah Rihn, et al.Journal of Virology|March 8, 2013
Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for FcγR2a and FcγR2bMargaret E Ackerman, Anne-Sophie Dugast, Elizabeth G McAndrew, et al.Plos One|June 6, 2014
KIR2DS4 promotes HIV-1 pathogenesis: new evidence from analyses of immunogenetic data and natural killer cell functionAimee M Merino, Anne-Sophie Dugast, Craig M Wilson, et al.Vaccines|July 27, 2022
Preclinical Immunogenicity and Efficacy of a Multiple Antigen-Presenting System (MAPSTM) SARS-CoV-2 VaccineBrian Cieslewicz, Daniel Makrinos, Heidi Burke, et al.Pageof 54